Intended for healthcare professionals

Student News

Drug company accused of breaking regulations

BMJ 2003; 326 doi: (Published 01 June 2003) Cite this as: BMJ 2003;326:0306180c
  1. Fabian Waechter1
  1. 1BMJ

The Drug and Therapeutics Bulletin has accused the drug company Novartis of breaching advertising regulations in its advertisement for pimecrolimus, a new cream for treating dermatitis (2003;41(5):33-6).

The bulletin was concerned that while the licence …

View Full Text

Log in

Log in through your institution


* For online subscription